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Abstract The carbohydrate binding properties of jacalin lectin
were examined using RAF9 cell-derived D-[6-3H]glucosamine-
radiolabeled total glycopeptides containing N-linked and O-
linked oligosaccharides. The binding of N-linked glycopeptides to
jacalin was abolished by treatment of K-galactosidase whereas
O-linked glycopeptides were still bound lectin after this
treatment. The removal of O-linked oligosaccharides by mild
alkaline/borohydride treatment completely eliminated the lectin
binding of K-galactosidase treated glycopeptides. These results
demonstrate that jacalin interacts with cellular glycopeptides
containing N-linked oligosaccharides with terminal K-galactose
residues as well as glycopeptides containing O-linked oligosac-
charides.
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1. Introduction
Jacalin lectin from jackfruit seeds, Artocarpus integrifolia
which belongs to Moraceae plant family, consists of two pol-
ypeptide chains, a heavy chain of K and a light chain of L
[1,2]. The cDNA analysis of jacalin revealed that lectin is
synthesized as a preproprotein and processed into functional
two-chain molecule by proteolytic cleavage [3]. The recent
analysis of X-ray crystal structure of jacalin showed that lec-
tin has tetrameric structure of heterodimer subunit (K/L), and
each subunit contains a unique carbohydrate binding site [4].
The carbohydrate binding property of Jacalin lectin has
been known to be highly speci¢c to T-antigenic disaccharide,
galL1,3GalNAc-O-KSer/Thr [5,6]. Due to its binding speci¢c-
ity toward O-linked oligosaccharide, jacalin has been used in
many applications of O-linked glycoprotein and glycopeptide
isolations [7^10]. However, there has been little information
about the interaction between jacalin and N-linked oligosac-
charides. In this study, we investigated the carbohydrate bind-
ing speci¢cities of jacalin using cellular N-linked glycopepti-
des. Our results demonstrate that glycopeptides containing
multi-antennary N-linked oligosaccharides with terminal
K-galactose residues can bind jacalin with high a⁄nity.
2. Materials and methods
2.1. Materials
Jacalin lectin and jacalin agarose were purchased from Vector
Laboratories (Burlingame, CA). Con A-Sepharose and CNBr-acti-
vated Sepharose 4B were obtained from Pharmacia LKB Biotech-
nology Inc. Sephadex G-25, K-methylgalactopyranoside, melibiose,
green co¡ee bean K-galactosidase, jack bean L1,4-galactosidase and
L1,4- N-acetylhexosaminidase were obtained from Sigma Chemical
Co., St. Louis, MO. K1,3/1,4-fucosidase was purchased from Takara
Shuzo Co. All-trans-retinoic acid was purchased from Eastman Ko-
dak Co. Neuraminidase (Arthrobacter ureafaciens) was obtained from
Boehringer Mannheim Co. Radioisotope D-[6-3H]glucosamine (25 Ci/
mmole) was purchased from ICN Pharmaceuticals, Irvine, CA. The
radioactive standard monosaccharides, N-acetyl[14C]galactosamine/
N-acetyl[3H]glucosamine, and radioactive standard sugar alco-
hols, N-acetyl[3H]glucosaminitol, N-acetyl[14C]galactosaminitol, and
GalL1,3GalNAcO[3H] were prepared as described previously [11].
2.2. Cell culture and metabolic radiolabeling of cellular glycoproteins
Mouse teratocarcinoma F9 cells were obtained from American
Type Culture Collection and monolayer cells were cultured in Dul-
becco’s modi¢ed Eagle’s medium supplemented with 15% fetal bovine
serum and antibiotics (100 units/ml of penicillin and 100 mg/ml of
streptomycin). F9 cells were induced to di¡erentiate into RAF9 cells
by treating retinoic acid (1037 M) for three days [12] and cells were
metabolically radiolabeled with D-[6-3H]glucosamine. F9 cells were
grown for 3 days in the medium supplemented with and without
retinoic acid and the cultures were fed with medium containing
200 WCi/ml D-[6-3H]glucosamine (25 Ci/mmole) for overnight. The
radiolabeled cells were solubilized with mild sonications in PBS con-
taining 0.1% Nonidet P-40 and protease inhibitors, and total glyco-
proteins were prepared by 10% TCA precipitation as previously de-
scribed [13]. The radiolabeled glycopeptides were prepared by Pronase
treatment (10 mg/ml) of total glycoproteins in digestion bu¡er (0.1 M
Tris-Cl containing 1 mM CaCl2, pH 8.0) under toluene atmosphere
[11].
2.3. Column chromatography and descending paper chromatography
Con A-Sepharose lectin column chromatography was carried out as
previously described [11]. The radioactive glycopeptides were fraction-
ated on a 2 ml column of Con A-Sepharose (0.7U5 cm) with 2 ml
collection of each fraction. The Jacalin-Sepharose 4B was prepared to
4 mg/ml of coupling density by manufacturer’s instructions using
CNBr-activated gel and jacalin lectin column chromatography was
performed as previously described [10]. The chromatography of gly-
copeptides on Sephadex G-25 was conducted on a column (1U68 cm)
equilibrated in 0.1 M pyridine-acetate bu¡er (pH 5.6). The descending
paper chromatography on Whatman No. 1 ¢lter paper of monosac-
charides and oligosaccharides was conducted in solvent A (n-butylal-
cohol/pyridine/water, 6:4:3) for composition analysis, and in solvent
B (ethyl acetate/pyridine/acetic acid/water, 5:5:1:3) for size separa-
tion, respectively [13]. The radioactivity on paper was determined
by cutting strip into 1 cm sections followed by measuring in a Beck-
man liquid scintillation counter.
2.4. L-elimination and exoglycosidase treatment
For mild alkaline borohydride treatment, radiolabeled glycopepti-
des were treated with 50 mM NaOH containing 1 M NaBH4 at 45‡C
for 16 h as described [11]. The reaction was terminated by neutraliza-
tion with 4 N glacial acetic acid. The K-galactosidase treatment was
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performed in either 50 mM sodium-acetate bu¡er (pH 6.0) or 10 mM
HEPES (pH 6.5) containing 150 mM NaCl and 5 mM CaCl2 at 37‡C
with 100 milliunits of enzyme, and other treatments of exoglycosidases
(L1,4-galactosidase, L-hexosaminidase, neuraminidase, and K1,3/1,4-
fucosidase) were conducted as previously described [13^15].
3. Results
In the present study, we describe our ¢nding that jacalin
has carbohydrate binding speci¢city to terminal K-galactose
residues present on cellular N-linked glycopeptides. Total gly-
copeptides prepared from metabolically D-[6-3H]glucosamine-
radiolabeled F9 and RAF9 cells were applied on a column of
jacalin lectin immobilized on Sepharose 4B and the bound
glycopeptides were isolated by elution with 100 mM K-meth-
ylgalactopyranoside (Fig. 1). As shown in Fig. 1A and B, 19^
20% of total radioactive glycopeptides from RAF9 cells were
bound jacalin whereas 6^7% were bound in case of F9 cell-
derived glycopeptides. Compared with other cell-derived gly-
copeptides, such as CHO and K562 cells, the glycopeptides
from RAF9 cells have been consistently shown to have a 3^4-
fold increase in jacalin binding (data not shown). It has been
well known that RAF9 cells exhibit several-fold increased ex-
pression of terminal K1,3-galactose on cellular glycoproteins
compared with F9 cells [18,19], and therefore we investigated
the possible interaction between jacalin and cellular glycopep-
tides containing terminal K-galactose residues.
The jacalin-bound RAF9 glycopeptides (Fig. 1A) were ap-
plied to a column of Sephadex G-25 for molecular sizing and
desalting as shown in Fig. 1C. The large sized glycopeptides in
the region of Vo of Sephadex G-25 column were pooled and
then applied to a column of Con A-Sepharose (Fig. 1D).
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Fig. 1. Serial column chromatography of cellular glycopeptides. D-[6-3H]glucosamine-radiolabeled total glycopeptides from RAF9 cells (A) and
F9 cells (B) were applied to a column of Jacalin-Sepharose 4B. The unbound glycopeptides (J-Unbound) and bound glycopeptides (J-Bound)
were fractionated by elution with 100 mM K-methyl-galactopyranoside (a-m-gal). The J-Bound glycopeptides from RAF9 cells were pooled as
indicated by horizontal bar and applied to a column of Sephadex G-25 for molecular sizing (C). The apparant Vo and Ve were pre-determined
with BSA and K-methylmannoside, respectively. The large sized glycopeptides were pooled as indicated and applied to a column of Con A-Se-
pharose (D). The Con A-bound glycopeptides were eluted sequentially with 10 mM K-methylglucoside (a-m-glc) and 100 mM K-methylmanno-
side (a-m-man). The fractions were pooled and designated as Con A-I (unbound), Con A-II (bound and eluted with 10 mM a-m-glc) and Con
A-III (bound and eluted with 100 mM a-m-man).
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Previous studies have shown that Con A-I fraction contains
both complex type N-linked oligosaccharides (tri-antennary,
tetra-antennary, and more branched) and O-linked oligosac-
charides [20]. However, complex type bi-antennary N-linked
oligosaccharides are contained in Con A-II, and high man-
nose type N-linked oligosaccharides are in Con A-III fraction
[20]. As shown in Fig. 1D, 70% of radioactivity designated as
Con A-I glycopeptides, 17% of radioactivity as Con A-II, and
13% of radioactivity as Con A-III were recovered, respec-
tively. Since the Con A-I glycopeptides (Fig. 1D) were con-
sidered to contain multi-antennary N-linked glycans and
O-linked glycans, these glycopeptides were pooled and used
to test further jacalin binding.
First, Con A-I glycopeptides were reapplied to Jacalin-Se-
pharose 4B, to con¢rm the lectin binding capacity. As ex-
pected, these glycopeptides were 100% rebound to jacalin
(Fig. 2A). Second, to explore whether the terminal K-galacto-
sylation on these glycopeptides could in£uence jacalin bind-
ing, these Con A-I glycopeptides were treated with K-galacto-
sidase for overnight up to three days for complete cleavage of
terminal K-galactose residues, and the treated samples were
applied to column of Jacalin-Sepharose 4B. As shown in
Fig. 2C and D, 35%, and 60% of applied radioactive samples
were passed through the jacalin column without binding after
overnight and after 3 day treatment, respectively. As a con-
trol, treatment of Con A-I glycopeptides by heat-inactivated
K-galactosidase, or by other exoglycosidases such as K-1,3/1,4-
fucosidase and L-1,4-galactosidase has no e¡ect on jacalin
binding (Fig. 2B). In parallel with this, the binding properties
of Con A-II and Con A-III glycopeptides (Fig. 1D) to jacalin
were examined and turned out to be not a¡ected by K-galac-
tosidase treatment (data not shown). These data indicate that
removal of terminal K-galactose residues from Con A-I gly-
copeptides resulted in signi¢cant abolishment of jacalin bind-
ing and terminal K-galactose residues contained in Con A-I
glycopeptides could directly participate in lectin binding.
The composition analysis of N-acetylglucosamine and N-
acetylgalactosamine of jacalin-unbound glycopeptides (£ow-
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Fig. 2. Jacalin-Sepharose 4B column chromatography of Con A-I glycopeptides before and after exoglycosidase treatments. The intact Con A-I
glycopeptides were reapplied to Jacalin-Sepharose 4B and eluted with 100 mM K-methyl-galactopyranoside (a-m-gal) (A). The Con A-I glyco-
peptides were treated with heat-inactivated K-galactosidase (circle), K-1,3/1,4-fucosidase (triangle) and L-1,4-galactosidase (square) and reapplied
to a column of Jacalin-Sepharose 4B (B). The Con A-I glycopeptides were treated with K-galactosidase for overnight (C) or for 3 days (D) and
the treated samples were subsequently reapplied to lectin column.
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through fractions in Fig. 2D) showed almost complete lack of
N-acetylgalactosamine, suggesting that these glycopeptides
contain mainly N-linked glycans, not O-linked glycans (Fig.
3). Third, to further investigate the binding properties of ja-
calin-bound glycopeptides after 3 day treatment of K-galacto-
sidase (Fig. 2D), the samples were further treated with mild
alkaline/borohydride to e¡ect L-elimination of O-linked oligo-
saccharides. The treated samples were then applied to a col-
umn of Jacalin-Sepharose 4B and as shown in Fig. 4, almost
all of the applied samples did not bind to lectin. These data
demonstrate that the residual lectin binding of glycopeptides
after exhaustive treatment of K-galactosidase (Fig. 2D) was
turned out to be due to interaction between jacalin and
O-linked glycans present on glycopeptides.
4. Discussion
Previous binding studies of various glycans to jacalin have
shown that jacalin selectively interacts with Thomsen-Frieden-
reich antigen (T-antigenic disaccharide, GalL1,3GalNAc-O-
Ser/Thr) [5]. It should be noted that GalNAc must be in K-
anomeric con¢guration for high a⁄nity binding of T-antigen-
ic disaccharide to jacalin since lectin has been known to
poorly interact with same disaccharide containing L-anomeric
con¢guration [6]. It has been also shown that K-linked, not L-
linked galactopyranoside, such as K-methylgalactopyranoside
or melibiose can be used as hapten sugar for elution of jacalin
agarose column [7,9]. These observations indicate that jacalin
may have high binding speci¢city toward K-anomers of galac-
topyranosides and 2-acetamido-2-deoxygalactopyranosides.
However, there is also report that jacalin has very poor
a⁄nity to terminal K-anomeric glycans, such as galK1,3-K-
methylgalactopyranoside, galK1,4-gal, A- and B-blood group
trisaccharides [6]. Consistent with this, it was found that the
synthetic trisaccharide, galK1,3-lactose or galK1,3-N-acetyllac-
tosamine has no signi¢cant a⁄nity to jacalin lectin [22].
Although the molecular basis for these observations has not
been clearly understood, our results suggest some possibility
that multiple orientation of terminal K-galactose residues
might be important for jacalin binding with high a⁄nity.
In addition, some previous studies have shown that glyco-
proteins containing only N-linked oligosaccharides did not
bind to jacalin [9]. Based on our results, however, it seems
likely that the structure of N-linked oligosaccharides in those
glycoproteins may lack terminal K-linked galactose residues.
Therefore, in particular, the approaches to de¢ne jacalin bind-
ing using cell-derived glycoproteins or glycopeptides needs to
be cautious since many glycoproteins synthesized from mam-
malian species except human and old world monkeys may
contain some possible N-linked oligosaccharide structures
with terminal K-galactose residues in addition to O-linked
oligosaccharides [21].
Results of the present study demonstrate that RAF9 cell-
derived N-linked glycopeptides bind to jacalin and this inter-
action is mediated by terminal K-galactose residues present on
multi-antennary structure of N-linked oligosaccharides.
Although the spacial conformation of terminal K-galactose
residues on multi-antennary oligosaccharides needs to be de-
termined, it is very likely that multiple residues of K-linked
galactose may be necessary for strong interaction with tetra-
meric subunit structure of jacalin lectin [4], and may enhance
the lectin binding with high avidity.
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Fig. 3. Descending paper chromatography of jacalin-unbound glyco-
peptides (from Fig. 2D) after treatment with 4 N HCl and subse-
quent reacetylation. The strong acid hydrolyzed samples were ana-
lyzed by descending paper chromatography for 50 h in solvent
system A. The arrow indicates the migration position of standard
monosaccharide of N-acetyl[3H]glucosamine (GlcNAc) and N-ace-
tyl[14C]galactosamine (GalNAc).
Fig. 4. Jacalin-Sepharose 4B column chromatography of jacalin-
bound glycopeptides (from Fig. 2D) after mild alkaline/borohydride
treatment for L-elimination. The L-eliminated samples were reap-
plied to lectin column and the bound materials were eluted with
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